Healthcare & Regulatory in Denmark Key Players - Lundbeck, Ferring Pharmaceuticals, Leo Pharma Market Analysis & Forecast 2017 to 2022

Healthcare & Regulatory in Denmark

Overview

Denmark is one of the largest healthcare markets, with a strong focus on pharma R&D. It spends approximately 10.4% of its GDP on healthcare. The pharmaceutical market declined from $3.87 billion in 2009 to $3.16 billion in 2016, at a negative CAGR of 2.7%. It is expected to decrease at a negative CAGR of 2.8% from $3.07 billion in 2017 to $2.74 billion in 2021.

The Danish medical device market was valued at $1.40 billion in 2009, which increased to $1.81 billion in 2016. The main segments were in vitro diagnostics, ophthalmic devices, cardiovascular devices, orthopedic devices and healthcare IT. The increasing elderly population and associated disease burden are expected to drive the growth of the pharmaceutical market. However, the government initiated price-cap agreements act as a major barrier for the pharmaceutical market.

Click here for sample report @ https://www.wiseguyreports.com/sample-request/3079945-countryfocus-healthcare-regulatory-and-reimbursement-landscape-denmark

 

Healthcare & Regulatory in Denmark Industry Major Outlook

The report provides information on the healthcare, regulatory, and reimbursement landscape in Denmark, and includes - 
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers 
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Lundbeck, Ferring Pharmaceuticals, Leo Pharma, Novo Nordisk and Orifarm) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, GE Healthcare, Roche Diagnostics, Essilor and Zimmer Biomet) 
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Denmark 
- Porter’s five forces analysis for pharmaceutical and medical devices market of Denmark 
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices 
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure 
- An overview of the opportunities for and challenges to growth in the Danish healthcare market.

Healthcare & Regulatory in Denmark - Competitive Analysis

Key players are making innovative developments in Healthcare & Regulatory in Denmark industry.  The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector

Scope

The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Sweden. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Sweden.

 Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis.

.Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/3079945-countryfocus-healthcare-regulatory-and-reimbursement-landscape-denmark

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

WISEGUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.